The company have demonstrably improved its progress of an novel treatment for cardiac amyloidosis, leveraging the compound. Early trial results suggests significant improvements for individuals affected from this https://attruby473861.review-blogger.com/63755996/bridgebio-advances-cardiac-amyloidosis-treatment-through-the-therapy